GSDMC and breast cancer: Among them, IL-18 [p = 0.015, HR(95%CI): 0.832(0.717–0.965)] was a protective factor as well as GSDMC [p = 0.044, HR(95%CI): 1.120(1.003–1.251)] and TIRAP [p = 0.025, HR(95%CI): 1.336(1.037–1.722)] were risk factors for breast cancer prognoses (Figure 3A).